The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Piscitelli Dominic since 2018.
This trader's CIK number is 1695028.
At the time of last reporting, Piscitelli Dominic was the Chief Financial Officer of Oric Pharmaceuticals, Inc.. (stock ticker symbol ORIC).
Also see all insider trading activities at Oric Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ANAB | 0 | $0 | 37,000 | $2,696,227 | 37,000 | $419,580 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ORIC | 0 | $0 | 60,000 | $617,414 | 0 | $0 |
| 2024 | ORIC | 0 | $0 | 8,851 | $73,295 | 24,042 | $0 |
| 2023 | ORIC | 0 | $0 | 5,282 | $45,340 | 14,042 | $0 |
| 2022 | ORIC | 60,000 | $321,600 | 0 | $0 | 0 | $0 |
2. Oric Pharmaceuticals, Inc. (ORIC)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-12-03 | ANAB | Option Ex | 37,000 | 11.34 | 419,580 |
| 2018-12-03 | ANAB | Sale | 37,000 | 72.87 | 2,696,227 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-01 | ORIC | Sale | 20,000 | 10.05 | 200,980 |
| 2025-06-23 | ORIC | Sale | 1,034 | 10.01 | 10,345 |
| 2025-06-24 | ORIC | Sale | 32,466 | 10.51 | 341,055 |
| 2025-06-12 | ORIC | Sale | 300 | 10.00 | 3,000 |
| 2025-06-10 | ORIC | Sale | 324 | 10.00 | 3,240 |
| 2025-06-11 | ORIC | Sale | 2,976 | 10.01 | 29,774 |
| 2025-06-06 | ORIC | Sale | 2,600 | 10.01 | 26,020 |
| 2025-06-09 | ORIC | Sale | 300 | 10.00 | 3,000 |
| 2024-12-15 | ORIC | Option Ex | 24,042 | .00 | 0 |
| 2024-12-16 | ORIC | Sale | 8,851 | 8.28 | 73,295 |
| 2023-12-15 | ORIC | Sale | 5,282 | 8.58 | 45,340 |
| 2023-12-15 | ORIC | Option Ex | 14,042 | .00 | 0 |
| 2022-03-31 | ORIC | Buy | 60,000 | 5.36 | 321,600 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Piscitelli Dominic (Chief Financial Officer of Oric Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.